Clinical trials
Active, not recruiting Phase 2 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2010 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 5 |
| 2018 | 6 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 9 |
| 2022 | 7 |
| 2023 | 6 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 50 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 8 |
| M.D. Anderson Cancer Center | 5 |
| AbbVie | 2 |
| CanariaBio Inc. | 2 |
| Hoffmann-La Roche | 2 |
| University Health Network, Toronto | 2 |
| Verastem, Inc. | 2 |
| ARCAGY/ GINECO GROUP | 1 |
| Alexander B Olawaiye, MD | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 50 |
| Fallopian Tube Neoplasms | 22 |
| Breast Neoplasms | 5 |
| Carcinoma, Ovarian Epithelial | 5 |
| Endometrial Neoplasms | 5 |
| Pancreatic Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Prostatic Neoplasms | 3 |
| Recurrence | 3 |
| Adenocarcinoma, Clear Cell | 2 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.